We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs.
- Authors
Duffy, Amanda L.; Olea-Popelka, Francisco J.; Eucher, James; Rice, Dahlia M.; Dow, Steven W.
- Abstract
Background: The chemokine monocyte chemoattractant protein-1 (MCP-1) is a primary regulator of monocyte mobilization from bone marrow, and increased concentrations of MCP-1 have been associated with sepsis and other inflammatory disorders in critically ill people. The relationship between MCP-1 and disease in dogs has not been evaluated previously. Objective: The purpose of this study was to assess serum concentrations of MCP-1 in healthy dogs, dogs in the postoperative period, and critically ill dogs. We hypothesized that MCP-1 concentrations would be significantly increased in critically ill dogs compared with postoperative or healthy dogs. Methods: Serum concentrations of MCP-1 were measured in 26 healthy control dogs, 35 postoperative dogs, and 26 critically ill dogs. Critically ill dogs were further subgrouped into dogs with sepsis, parvovirus gastroenteritis, immune-mediated hemolytic anemia, and severe trauma ( n=26). MCP-1 concentrations were determined using a commercial canine MCP-1 ELISA. Associations between MCP-1 concentrations and disease status were evaluated statistically. Results: MCP-1 concentration was significantly higher in critically ill dogs (median 578 pg/mL, range 144.7–1723 pg/mL) compared with healthy dogs (median 144 pg/mL, range 4.2–266.8 pg/mL) and postoperative dogs (median 160 pg/mL, range 12.6–560.4 pg/mL) ( P<.001). All subgroups of critically ill dogs had increased MCP-1 concentrations with the highest concentrations occurring in dogs with sepsis. However, differences among the 4 subgroups were not statistically significant. Conclusion: Critically ill dogs had markedly increased serum concentrations of MCP-1 compared with postoperative and healthy dogs. These results indicate that surgery alone is not sufficient to increase MCP-1 concentrations; thus, measurement of MCP-1 may be useful in assessing disease severity in critically ill dogs.
- Subjects
ANIMAL health; DOGS; MONOCYTES; BONE marrow; AUTOIMMUNITY; CHEMOKINES; CHEMOTAXIS; SEPSIS
- Publication
Veterinary Clinical Pathology, 2010, Vol 39, Issue 3, p302
- ISSN
0275-6382
- Publication type
Article
- DOI
10.1111/j.1939-165X.2010.00228.x